KNSA - CIK 0001730430
As of 2026-05-29, Kiniksa Pharmaceuticals, Ltd. (KNSA) has a market capitalization of $3.75 B, making it the #1635 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-05-29 | $3.75 B |
| 2026-05-28 | $3.99 B |
| 2026-05-26 | $4.08 B |
| 2026-05-25 | $4.10 B |
| 2026-05-24 | $4.10 B |
| 2026-05-22 | $4.10 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-05-29, Kiniksa Pharmaceuticals, Ltd. (KNSA) has a market capitalization of $3.75 B, making it the #1635 most valuable US-listed company.
Kiniksa Pharmaceuticals, Ltd. is the #1635 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.